Evolent Health Announces Fourth Quarter and Full Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Evolent Health (EVH) Tops Q4 EPS by 7c
February 23, 2022 4:13 PM ESTEvolent Health (NYSE: EVH) reported Q4 EPS of $0.08, $0.07 better than the analyst estimate of $0.01. Revenue for the quarter came in at $248.4 million versus the consensus estimate of $233.88 million.
GUIDANCE:
Evolent Health sees FY2022 revenue of $1.12-1.18 billion, versus the consensus of... More
